culmerciclib (TQB3616)

News alerts, weekly reports and conference planners

Company:

Sino Biopharm

Drug class:

CDK4 inhibitor, CDK6 inhibitor, CDK2 inhibitor

Related drugs:

‹

›

ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	TQB3616 Sensitive: C2 – Inclusion Criteria TQB3616 Sensitive : C2	TQB3616 Sensitive: C2 – Inclusion Criteria TQB3616 Sensitive : C2
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	TQB3616 Sensitive: D – Preclinical TQB3616 Sensitive : D	TQB3616 Sensitive: D – Preclinical TQB3616 Sensitive : D

Associations
(2)